COMMUNIQUÉ DE PRESSE publié le 05/01/2024 à 16:58, il y a 1 année 2 mois Spiden Announces Breakthrough in Non-Invasive Glucose Monitoring, Adds Key Executive Hires and Secures $15m in Additional Funding Spiden, a pioneer in non-invasive biomarker monitoring technology, has reached an important scientific milestone in non-invasive glucose sensing technology. The company has also made significant additions to its executive team, secured an oversubscribed convertible note, and commenced measurements in diabetes centers in multiple countries. Spiden aims to launch its non-invasive glucose monitoring wearable by the end of 2025 and expand to other biomarkers, setting a new standard in personalized health monitoring. Spiden Non-invasive Biomarker Monitoring Glucose Sensing Wearable Technology Personalized Health Monitoring
Publié le 01/04/2025 à 17:45, il y a 7 heures 22 minutes Covivio Hotels - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Publié le 01/04/2025 à 17:45, il y a 7 heures 22 minutes Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Publié le 01/04/2025 à 17:45, il y a 7 heures 22 minutes Covivio - Information on total number of voting rights and share capital
Publié le 01/04/2025 à 17:35, il y a 7 heures 32 minutes Déclaration hebdomadaire d'opérations effectuées du 24 au 31 mars 2025
Publié le 01/04/2025 à 16:00, il y a 9 heures 7 minutes e Groupe Freeland, soutenu majoritairement par MML, accompagné de IDI et BPI, finalise sa 7ème opération de croissance externe en 6 ans
Publié le 01/04/2025 à 23:35, il y a 1 heure 32 minutes Amaze Deepens Adobe Express Partnership with New Add-On Experience
Publié le 01/04/2025 à 23:20, il y a 1 heure 47 minutes RE Royalties Enters into a Letter of Intent to provide a Secured Loan to Revolve for US $8,000,000 to Finance Acquisition of a 9.6 MW Operating Wind Project in the United States
Publié le 01/04/2025 à 23:05, il y a 2 heures 2 minutes Kingstone Announces Resignation of Chief Financial Officer; Reiterates Guidance for Full Year 2025
Publié le 01/04/2025 à 22:15, il y a 2 heures 52 minutes Jaguar Health Announces Closing of Bridge Financing Priced At-The-Market Under Nasdaq Rules
Publié le 01/04/2025 à 21:30, il y a 3 heures 37 minutes Organto Foods Announces Increase to Private Placement Financing
Publié le 01/04/2025 à 20:55, il y a 4 heures 12 minutes Viromed Medical AG: UMECO Group acquires exclusive marketing rights in Asia for cold plasma medical devices ViroCAP® and PulmoPlas®
Publié le 01/04/2025 à 19:55, il y a 5 heures 11 minutes CHAPTERS Announces the Result of the Buyback Offer for the 2020 Perpetual Bond
Publié le 01/04/2025 à 19:05, il y a 6 heures 1 minute Annual General Meeting of Intershop Holding AG approves all proposals from the Board of Directors
Publié le 01/04/2025 à 19:05, il y a 6 heures 2 minutes Funding Circle Plc: POS-Transaction in Own Shares
Publié le 01/04/2025 à 19:00, il y a 6 heures 7 minutes Dalata Hotel Group PLC: DSH-Director/PDMR Shareholding*